Review
Published on 11 Dec 2025
Unraveling the RKIP–YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1675699
- 703 views
Type at least 3 characters
48,714 articles
articles
Original Research
Published on 11 Dec 2025
Identification of serum MicroRNAs associated with hepatic immunoinflammatory injury in chronic hepatitis B: implications for non-invasive diagnosis
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1671149
- 727 views
Original Research
Published on 11 Dec 2025
Prognostic significance of reduced handgrip strength in patients with unresectable hepatocellular carcinoma receiving HAIC combined with targeted immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1672519
- 483 views
Original Research
Published on 11 Dec 2025
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1640603
- 791 views
Original Research
Published on 11 Dec 2025
Mitochondrial calcium shapes B cell signaling and mitochondrial function
in B Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1710128
- 582 views
Review
Published on 11 Dec 2025
T cell heterogeneity in asthma pathogenesis: from immunological mechanisms to biological targeted therapies
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1658774
- 513 views
Mini Review
Published on 11 Dec 2025
Tumor associated macrophages in gastric cancer dual roles in immune evasion and clinical implications for targeted therapy
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1706744
- 762 views
Systematic Review
Published on 11 Dec 2025
Incidence, risk factors and outcomes of BCGosis following BCG vaccination in infants: a systematic review and meta-analyses
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1615039
- 979 views
Brief Research Report
Published on 11 Dec 2025
Plasmodium vivax infection-driven modulation of sterol carrier protein reveals a metabolic link to reproductive physiology in Anopheles stephensi
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1703479
- 790 views
Original Research
Published on 11 Dec 2025
Evaluation of programmed cell death ligand-1 expression in primary central nervous system lymphoma using whole-tumor histogram analysis of multiparametric MRI: implications for immunotherapy selection
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1676273
- 517 views
Review
Published on 11 Dec 2025
Experimental animal models of acute respiratory distress syndrome: one-hit and two-hit establishment application
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1649074
- 654 views
Original Research
Published on 11 Dec 2025
Macrophage activation of the TREM2-DAP12-SYK pathway shapes the adipose tissue microenvironment in obesity and unveils the therapeutic potential of natural compounds egcg and SMRR
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1694985
- 1,101 views
Case Report
Published on 11 Dec 2025
Case report of acute hepatorenal failure induced by third-line treatment with tislelizumab in a patient with cholangiocarcinoma: was influenza virus the culprit?
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1631953
- 591 views
Original Research
Published on 11 Dec 2025
Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell function
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1717133
- 1,056 views
Original Research
Published on 11 Dec 2025
Therapeutic drug monitoring plays an important role in patients with noninfectious uveitis receiving adalimumab
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1733644
- 470 views
Clinical Trial
Published on 11 Dec 2025
Phase 1 study of chidamide in combination with venetoclax, azacitidine, aclarubicin, cytarabine and G-CSF for refractory/relapsed acute myeloid leukemia: clinical safety, efficacy, and correlative analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1698710
- 592 views
Original Research
Published on 11 Dec 2025
Fruquintinib saddles tumor immune tolerance by curbing pro-tumoral immature myeloid cell populations
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1699980
- 765 views
Review
Published on 11 Dec 2025
Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review
in Nutritional Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1701504
- 703 views
Original Research
Published on 11 Dec 2025
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1703026
- 852 views
Review
Accepted on 10 Dec 2025
Autoimmune Disease-Associated Lymphomas: Research Progress and Review
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
- 309 views
Original Research
Accepted on 10 Dec 2025
Cadonilimab Rechallenge in Patients with Recurrent or Metastatic Cervical Cancer Following Prior PD-1/PD-L1 Inhibitor Failure: A Retrospective Multicenter Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 291 views
Original Research
Accepted on 10 Dec 2025
Contrasting Immune Responses in COVID-19: Insights from Healthcare Workers and Infected Patients on Plasmablast, pDC, and NK Cell Dynamics
in Viral Immunology
Frontiers in Immunology
- 287 views
Original Research
Accepted on 10 Dec 2025
NOS2/ARG1 Axis and Immune Cell Ratios as promising prognostic and predictive Biomarkers for Cetuximab combined with chemotherapy in wt-KRAS human colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 355 views
Clinical Trial
Accepted on 10 Dec 2025
Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid® in a Long COVID cohort: a case series
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 343 views